SPANXA2, SPANX family member A2, 728712

N. diseases: 30; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 Biomarker group BEFREE In addition, certain members of CTAs, including Piwil2, DNAJB8, CT45A1, MAGE-A, GAGE, and SPANX, are implicated in the initiation or maintenance, of cancer stem-like cells, promoting tumorigenesis and malignant progression. 25506890 2015
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE In addition, certain members of CTAs, including Piwil2, DNAJB8, CT45A1, MAGE-A, GAGE, and SPANX, are implicated in the initiation or maintenance, of cancer stem-like cells, promoting tumorigenesis and malignant progression. 25506890 2015
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 Biomarker group BEFREE However, 3 cancer/testis antigen genes (PAGE4, SCP-1, and SPANX) and 3 clinicopathologic parameters (lymph node involvement, vessel cancer embolus, and tumor invasion depth) correlated significantly with liver metastasis of colorectal cancer (P < .05). 20010347 2010
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE However, 3 cancer/testis antigen genes (PAGE4, SCP-1, and SPANX) and 3 clinicopathologic parameters (lymph node involvement, vessel cancer embolus, and tumor invasion depth) correlated significantly with liver metastasis of colorectal cancer (P < .05). 20010347 2010
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 Biomarker group BEFREE Human sperm protein associated with the nucleus on the X chromosome (SPANX) genes comprise a gene family with five known members (SPANX-A1, -A2, -B, -C, and -D), encoding cancer/testis-specific antigens that are potential targets for cancer immunotherapy. 14973187 2004
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 Biomarker group BEFREE The data herein suggest that the SPAN-X protein may be a useful target in cancer immunotherapy. 14734458 2004
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE The data herein suggest that the SPAN-X protein may be a useful target in cancer immunotherapy. 14734458 2004
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE Human sperm protein associated with the nucleus on the X chromosome (SPANX) genes comprise a gene family with five known members (SPANX-A1, -A2, -B, -C, and -D), encoding cancer/testis-specific antigens that are potential targets for cancer immunotherapy. 14973187 2004
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.030 AlteredExpression disease BEFREE In this study, we determined the mechanisms regulating SPAN-Xb expression in MM. 16187275 2006
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.030 Biomarker disease BEFREE SPAN-Xb is a novel cancer-testis antigen in multiple myeloma. 17036333 2006
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.030 AlteredExpression disease BEFREE Based on these data, we conclude that SPAN-Xb is a novel member of the family of cancer/testis antigens aberrantly expressed by, and capable of inducing, immune responses in patients with multiple myeloma and other hematologic malignancies. 12393489 2003
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.020 Biomarker phenotype BEFREE SPANXA suppressed the invasion and metastasis of lung cancer cells in vitro and in vivo. 27323831 2016
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.020 Biomarker phenotype BEFREE In addition, certain members of CTAs, including Piwil2, DNAJB8, CT45A1, MAGE-A, GAGE, and SPANX, are implicated in the initiation or maintenance, of cancer stem-like cells, promoting tumorigenesis and malignant progression. 25506890 2015
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.020 AlteredExpression phenotype BEFREE However, 3 cancer/testis antigen genes (PAGE4, SCP-1, and SPANX) and 3 clinicopathologic parameters (lymph node involvement, vessel cancer embolus, and tumor invasion depth) correlated significantly with liver metastasis of colorectal cancer (P < .05). 20010347 2010
CUI: C0025202
Disease: melanoma
melanoma
0.020 Biomarker disease BEFREE A statistical significant difference for a particular class of SPANX-C gene was found comparing patients with melanoma and controls (P=0.011). 18626316 2008
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.020 GeneticVariation disease BEFREE Mutational analysis of SPANX genes in families with X-linked prostate cancer. 17373721 2007
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.020 GeneticVariation disease BEFREE Mutational analysis of SPANX genes in families with X-linked prostate cancer. 17373721 2007
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.020 Biomarker phenotype BEFREE The function of SpanX proteins is unknown, evidence is accumulating to suggest their involvement in tumorigenesis. 17204091 2006
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.020 GeneticVariation disease BEFREE We speculate that the predisposition to prostate cancer in X-linked families is an example of a genomic disease caused by a specific architecture of the SPANX gene cluster. 16251457 2005
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.020 GeneticVariation disease BEFREE We speculate that the predisposition to prostate cancer in X-linked families is an example of a genomic disease caused by a specific architecture of the SPANX gene cluster. 16251457 2005
CUI: C0025202
Disease: melanoma
melanoma
0.020 Biomarker disease BEFREE Immunoperoxidase labeling of melanoma cells and tissue sections demonstrated SPAN-X protein localization in the nucleus, cytoplasm, or both. 14734458 2004
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.010 AlteredExpression phenotype BEFREE In conclusion, we found that SPANX-C expression could play a role in tumor progression of uveal melanoma. 31072624 2019
CUI: C0220633
Disease: Uveal melanoma
Uveal melanoma
0.010 AlteredExpression disease BEFREE In conclusion, we found that SPANX-C expression could play a role in tumor progression of uveal melanoma. 31072624 2019
CUI: C4725091
Disease: metastatic intraocular melanoma
metastatic intraocular melanoma
0.010 Biomarker disease BEFREE Immunoexpression of SPANX-C in metastatic uveal melanoma. 31072624 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.010 Biomarker phenotype BEFREE SPANXA suppressed the invasion and metastasis of lung cancer cells in vitro and in vivo. 27323831 2016